These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 29608387)

  • 1. Rapid Determination of Resistance to Antibiotic Inhibitors of Protein Synthesis in Staphylococcus aureus Through In Situ Evaluation of DNase Activity.
    Otero F; Santiso R; López I; Touzón I; Gosálvez J; Bou G; Fernández JL
    Microb Drug Resist; 2018; 24(6):739-746. PubMed ID: 29608387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell wall active antibiotics reduce chromosomal DNA fragmentation by peptidoglycan hydrolysis in Staphylococcus aureus.
    Tamayo M; Santiso R; Gosálvez J; Bou G; Fernández Mdel C; Fernández JL
    Arch Microbiol; 2012 Dec; 194(12):967-75. PubMed ID: 22797526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid Assessment of Resistance to Antibiotic Inhibitors of Protein Synthesis in the Gram-Positive Pathogens, Enterococcus faecalis and Streptococcus pneumoniae, Based on Evaluation of the Lytic Response.
    Otero F; Tamayo M; Santiso R; Gosálvez J; Bou G; Fernández JL
    Microb Drug Resist; 2017 Apr; 23(3):267-271. PubMed ID: 27383851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM; Kokai-Kun JF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Influence of Polycations on Antibacterial Activity of Lysostaphin].
    Kulikov SN; Khairullin RZ; Varlamov VP
    Prikl Biokhim Mikrobiol; 2015; 51(6):610-5. PubMed ID: 26859963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.
    Szweda P; Schielmann M; Frankowska A; Kot B; Zalewska M
    J Vet Med Sci; 2014 Mar; 76(3):355-62. PubMed ID: 24212507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotic inhibition of translation and 50S ribosomal subunit assembly in methicillin-resistant Staphylococcus aureus cells.
    Champney WS; Burdine R
    Microb Drug Resist; 1998; 4(3):169-74. PubMed ID: 9818968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin.
    Francius G; Domenech O; Mingeot-Leclercq MP; Dufrêne YF
    J Bacteriol; 2008 Dec; 190(24):7904-9. PubMed ID: 18835985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of in-vitro-selected daptomycin-non-susceptibility in Staphylococcus aureus.
    Patel D; Husain M; Vidaillac C; Steed ME; Rybak MJ; Seo SM; Kaatz GW
    Int J Antimicrob Agents; 2011 Nov; 38(5):442-6. PubMed ID: 21840181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Staphylococcus aureus mutants with increased lysostaphin resistance.
    Gründling A; Missiakas DM; Schneewind O
    J Bacteriol; 2006 Sep; 188(17):6286-97. PubMed ID: 16923896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus.
    Climo MW; Ehlert K; Archer GL
    Antimicrob Agents Chemother; 2001 May; 45(5):1431-7. PubMed ID: 11302806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysostaphin: an antistaphylococcal agent.
    Kumar JK
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S; Coote PJ
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC; Foster-Frey J; Donovan DM
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.
    Koehl JL; Muthaiyan A; Jayaswal RK; Ehlert K; Labischinski H; Wilkinson BJ
    Antimicrob Agents Chemother; 2004 Oct; 48(10):3749-57. PubMed ID: 15388430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lytic action of lysostaphin on susceptible and resistant strains of Staphylococcus aureus.
    Zygmunt WA; Browder HP; Tavormina PA
    Can J Microbiol; 1967 Jul; 13(7):845-53. PubMed ID: 6036889
    [No Abstract]   [Full Text] [Related]  

  • 18. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
    Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
    Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Identification of Serine Hydroxymethyltransferase as a Key Gene Involved in Lysostaphin Resistance and Virulence Potential of
    Batool N; Ko KS; Chaurasia AK; Kim KK
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33266291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus resistance to antibiotics and spread of phage types.
    Kareiviene V; Pavilonis A; Sinkute G; Liegiūte S; Gailiene G
    Medicina (Kaunas); 2006; 42(4):332-9. PubMed ID: 16687905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.